Antoinette Birs is a Cardiology physician affiliated with University of California San Diego. OpenAlex indexes 50 publications with 433 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
Sponsor: University of California, San Diego
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
52%SGLT2 inhibitor52%Jardiance100%Part D<11 patientsCardiovascular
48%Statin48%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Guideline-Directed Medical Therapy Trends in the United States: An Analysis of Three Million Individuals
Journal of Cardiac Failure
2026 - Predicting sudden cardiac death in heart failure with reduced ejection fraction
Heart Failure Reviews
2026 - 26-A-9942-ACC LIPOPROTEIN(A) AND OXIDIZED PHOSPHOLIPIDS-APOLIPOPROTEIN B, BIOMARKERS OF RISK IN CARDIAC TRANSPLANT OUTCOMES
Journal of the American College of Cardiology
2026 - Insights from a real-world experience with inclisiran at a large United States lipid clinic
Journal of clinical lipidology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Richman, MD
University of California San Diego
Robert Weinreb, MD
University of California San Diego
Irene Litvan, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”